Summary Mount Tam Biotechnologies Inc (Mount Tam Biotechnologies), a subsidiary of TabacaleraYsidron Inc is a provider of pharmaceutical products that focuses on the development and commercialization of medical compounds for autoimmune diseases. The company’s lead product candidate TAM-0, a rapamycin analog that exerts its action through direct binding and inhibition of the mammalian Target Of Rapamycin. Mount Tam Biotechnologies TAM-01 is developed for the treatment of systemic lupus erythematosus. Its pipeline product includes TAM-02, which is used for multiple sclerosis. The company works in partnership with Buck Institute for Research on Aging for the development of medical compounds in the area of autoimmune disorders. Mount Tam Biotechnologies is headquartered in Novato, California, the US. Mount Tam Biotechnologies Inc (MNTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.... Research Beam Model: Research Beam Product ID: 2114209 250 USD New
Mount Tam Biotechnologies Inc (MNTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Mount Tam Biotechnologies Inc (MNTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : September   2017
  • Pages : 22
  • Publisher : GlobalData
 
 
 
Summary

Mount Tam Biotechnologies Inc (Mount Tam Biotechnologies), a subsidiary of TabacaleraYsidron Inc is a provider of pharmaceutical products that focuses on the development and commercialization of medical compounds for autoimmune diseases. The company’s lead product candidate TAM-0, a rapamycin analog that exerts its action through direct binding and inhibition of the mammalian Target Of Rapamycin. Mount Tam Biotechnologies TAM-01 is developed for the treatment of systemic lupus erythematosus. Its pipeline product includes TAM-02, which is used for multiple sclerosis. The company works in partnership with Buck Institute for Research on Aging for the development of medical compounds in the area of autoimmune disorders. Mount Tam Biotechnologies is headquartered in Novato, California, the US.

Mount Tam Biotechnologies Inc (MNTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Mount Tam Biotechnologies Raises USD1 Million in Venture Financing 10
Partnerships 11
Mount Tam Biotech Enters into Ageement with University of Chile 11
Mount Tam Biotechnologies Enters into Agreement with Isomerase Therapeutics 12
Licensing Agreements 13
Mount Tam Enters into Licensing Agreement with Buck Institute 13
Acquisition 14
Mount Tam Biotech Acquires TabacaleraYsidron in Reverse Merger Transaction 14
Mount Tam Biotechnologies Inc - Key Competitors 15
Mount Tam Biotechnologies Inc - Key Employees 16
Mount Tam Biotechnologies Inc - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Apr 22, 2016: Mount Tam Biotechnologies, Inc. Announces the Appointment of Jim Stapleton as Chief Financial Officer 18
Mar 24, 2016: Mount Tam Biotechnologies Announces the Appointment of Richard Marshak as CEO 19
Product News 20
06/30/2017: Mount Tam Biotechnologies Announces Data on TAM-03 20
02/13/2017: Mount Tam Biotechnologies Announces TAM-03, a Novel Compound with Potential to Treat a Range of Cancer Types 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mount Tam Biotechnologies Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Mount Tam Biotechnologies Raises USD1 Million in Venture Financing 10
Mount Tam Biotech Enters into Ageement with University of Chile 11
Mount Tam Biotechnologies Enters into Agreement with Isomerase Therapeutics 12
Mount Tam Enters into Licensing Agreement with Buck Institute 13
Mount Tam Biotech Acquires TabacaleraYsidron in Reverse Merger Transaction 14
Mount Tam Biotechnologies Inc, Key Competitors 15
Mount Tam Biotechnologies Inc, Key Employees 16
List of Figures
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mount Tam Biotechnologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter